Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Capital Expenditures (2022 - 2025)

Core Laboratories' Capital Expenditures history spans 4 years, with the latest figure at -$6.8 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 8725.32% year-over-year to -$6.8 million; the TTM value through Dec 2025 reached $1.5 million, down 13.11%, while the annual FY2025 figure was $1.5 million, 13.11% down from the prior year.
  • Capital Expenditures reached -$6.8 million in Q4 2025 per CLB's latest filing, down from $7.4 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $9.5 million in Q4 2022 to a low of -$6.8 million in Q4 2025.
  • Average Capital Expenditures over 4 years is $1.6 million, with a median of $1.2 million recorded in 2024.
  • The largest YoY upside for Capital Expenditures was 3095.71% in 2025 against a maximum downside of 8725.32% in 2025.
  • A 4-year view of Capital Expenditures shows it stood at $9.5 million in 2022, then plummeted by 100.8% to -$76000.0 in 2023, then skyrocketed by 203.95% to $79000.0 in 2024, then plummeted by 8725.32% to -$6.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Capital Expenditures are -$6.8 million (Q4 2025), $7.4 million (Q3 2025), and -$2.0 million (Q2 2025).